Rafferty Asset Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.77M Buy
188,220
+6,359
+3% +$229K 0.02% 340
2025
Q1
$7.17M Sell
181,861
-149,551
-45% -$5.9M 0.03% 307
2024
Q4
$9.98M Sell
331,412
-9,057
-3% -$273K 0.04% 290
2024
Q3
$7.96M Buy
340,469
+3,505
+1% +$82K 0.03% 318
2024
Q2
$5.99M Sell
336,964
-209,555
-38% -$3.73M 0.02% 380
2024
Q1
$8.31M Sell
546,519
-24,607
-4% -$374K 0.03% 337
2023
Q4
$9.75M Sell
571,126
-285,711
-33% -$4.88M 0.04% 287
2023
Q3
$7.16M Buy
856,837
+554,309
+183% +$4.63M 0.04% 315
2023
Q2
$7.51M Sell
302,528
-180,507
-37% -$4.48M 0.04% 309
2023
Q1
$7.26M Sell
483,035
-268,744
-36% -$4.04M 0.05% 279
2022
Q4
$8.89M Sell
751,779
-21,431
-3% -$254K 0.07% 215
2022
Q3
$4.58M Buy
773,210
+161,805
+26% +$958K 0.05% 348
2022
Q2
$2.6M Buy
611,405
+3,780
+0.6% +$16.1K 0.02% 416
2022
Q1
$5.78M Buy
607,625
+289,391
+91% +$2.75M 0.03% 344
2021
Q4
$6.05M Buy
318,234
+213,638
+204% +$4.06M 0.03% 299
2021
Q3
$3.48M Buy
104,596
+35,537
+51% +$1.18M 0.02% 402
2021
Q2
$2.68M Buy
69,059
+2,195
+3% +$85.2K 0.02% 550
2021
Q1
$3.22M Buy
66,864
+44,811
+203% +$2.16M 0.02% 439
2020
Q4
$1.15M Sell
22,053
-57,600
-72% -$3M 0.01% 473
2020
Q3
$2.13M Buy
79,653
+24,096
+43% +$645K 0.03% 398
2020
Q2
$1.08M Buy
55,557
+44,830
+418% +$873K 0.02% 522
2020
Q1
$106K Sell
10,727
-80,336
-88% -$794K ﹤0.01% 556
2019
Q4
$1.01M Sell
91,063
-142,277
-61% -$1.58M 0.02% 550
2019
Q3
$1.31M Sell
233,340
-79,433
-25% -$446K 0.02% 483
2019
Q2
$2.71M Buy
312,773
+160,887
+106% +$1.39M 0.05% 283
2019
Q1
$1.22M Buy
+151,886
New +$1.22M 0.02% 511